Kabra Drugs Ltd.

6.85 0.00

26 February 2024, 12:22:00 PM
Volume: 279

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kabradrugs.com
Market Cap 3.01 Cr.
Enterprise Value(EV) 4.61 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.16 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.88 Trailing Twelve Months Ending 2023-12
Book Value / Share -2.50 Trailing Twelve Months Ending 2023-12
Price to Book Value -2.74 Calculated using Price: 6.85
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.44 Cr. 4,388,600 Shares
FaceValue 10
About Kabra Drugs Ltd.
The company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.

Kabra Drugs Ltd. Delivery

Delivered Qty
Traded Qty

Kabra Drugs Ltd. Performance

1 Day
1 Week
1 Month
+4.90%
3 Month
+33.79%
6 Month
+50.55%
1 Year
+28.76%
2 Year
+31.23%
5 Year
+1004.84%
10 Year
-30.60%

Kabra Drugs Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.55 1.05 5.02 -171.4 -144.2 -2869.33 0 0 0
Return on Capital Employed (%) 3.52 5.81 7.49 -80.09 -19.67 -8.82 -27.33 -27.96 -52.6
Return on Assets (%) 0.79 0.31 1.67 -58.3 -10.36 -4.11 -12.78 -17.39 -47.15

Kabra Drugs Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3 3 3 0 0 0 0 0 -1 -1
Non Curr. Liab. 3 2 1 0 0
Curr. Liab. 3 4 3 1 1 1 2 1 1 2
Minority Int.
Equity & Liab. 9 9 6 2 1 1 1 1 1 1
Non Curr. Assets 3 3 3 0 0 0 0 0 0 0
Curr. Assets 6 6 4 1 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 9 9 6 2 1 1 1 1 1 1

Kabra Drugs Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 8 10 8 2
Other Income 0 0 0 0 0 0 0
Total Income 8 10 8 2 0 0 0
Total Expenditure -8 -9 -7 -3 0 0 0 0 0 -1
PBIDT 0 0 1 -1 0 0 0 0 0 -1
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0
Taxation 0 0 0
Exceptional Items -1
PAT 0 0 0 -2 0 0 0 0 0 -1
Adjusted EPS 0 0 0 -5 0 0 0 0 -1 -1

Kabra Drugs Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0 0 2 0 0
Cash Fr. Finan. 0 1 0 0 -1 0 0 0 0
Net Change 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Kabra Drugs Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kabra Drugs Ltd. Announcements

Mon, 19 Feb 2024
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Result of EGM held on 17th February 2024
Sat, 17 Feb 2024
Shareholder Meeting / Postal Ballot-Outcome of EGM
Outcome of EGM held on Saturday 17 February 2024
Fri, 16 Feb 2024
Submission Of Statement Of Investor Grievances Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Pursuant to Regulation 13(3) of SEBI (LODR) Regulation 2015 we hereby furnish below the statement of Investor Grievances for the quarter ended September 30 2019.

Kabra Drugs Ltd. Technical Scans

Mon, 19 Feb 2024
Opening at High Opening at High
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Kabra Drugs Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,556.25 -0.3%
Cipla Ltd. 118,375.92 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,641.80 -2.0%
Divi's Laboratories Ltd. 96,748.70 3,575.85 -2.0%
Zydus Lifesciences Ltd. 93,335.34 937.45 +1.5%
Torrent Pharmaceuticals Ltd. 88,913.00 2,617.05 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,556.25 -0.3%
Cipla Ltd. Consolidated 2023-12 31.92 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,641.80 -2.0%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,575.85 -2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 937.45 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,617.05 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,556.25 -0.3%
Cipla Ltd. Consolidated 2023-12 4.57 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,641.80 -2.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,575.85 -2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 937.45 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,617.05 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,556.25 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,641.80 -2.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,575.85 -2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 937.45 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,617.05 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,556.25 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,641.80 -2.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,575.85 -2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 937.45 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,617.05 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,556.25 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,641.80 -2.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,575.85 -2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 937.45 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,617.05 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,556.25 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,641.80 -2.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,575.85 -2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 937.45 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,617.05 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,556.25 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,464.25 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,384.75 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,641.80 -2.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,575.85 -2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 937.45 +1.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,617.05 -0.4%

Kabra Drugs Ltd. FAQ's

What is Kabra Drugs share price?

Can I buy Kabra Drugs shares now?

What is the Market Cap of Kabra Drugs?

What is the 52 Week High and Low of Kabra Drugs?

What is the trend of Kabra Drugs share price?